Neurophysiologic and intellectual evaluation of beta-thalassemia patients
- 1 January 2006
- journal article
- research article
- Published by Elsevier in Brain and Development
- Vol. 28 (1) , 14-18
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Survival in β-thalassaemia major in the UK: data from the UK Thalassaemia RegisterThe Lancet, 2000
- Focal Neurological Deficits in Children with β-Thalassemia MajorNeuropediatrics, 1999
- Neurophysiologic Study of β-Thalassemia PatientsJournal of Child Neurology, 1993
- Peripheral neuropathy in patients with beta-thalassaemia.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Vision and hearing during deferoxamine therapyThe Journal of Pediatrics, 1990
- Desferrioxamine ototoxicity: evaluation of risk factors in thalassaemic patients and guidelines for safe dosageBritish Journal of Haematology, 1989
- Reversal of desferrioxamine induced auditory neurotoxicity during treatment with Ca-DTPA.Archives of Disease in Childhood, 1989
- Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia.Archives of Disease in Childhood, 1988
- Visual and Auditory Neurotoxicity in Patients Receiving Subcutaneous Deferoxamine InfusionsNew England Journal of Medicine, 1986
- VISUAL LOSS IN PATIENT ON HIGH-DOSE SUBCUTANEOUS DESFERRIOXAMINEThe Lancet, 1984